Reich K - Search Results

1

Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis.

Reich K, Baraliakos X, Coates LC, Elewski B, Bao W, Kasparek T, Gaillez C, Pournara E, Aassi M, Perella C, Gottlieb AB. Reich K, et al. Br J Dermatol. 2022 Sep;187(3):438-441. doi: 10.1111/bjd.21233. Epub 2022 Jun 7. Br J Dermatol. 2022. PMID: 35257363 Clinical Trial.

2

Treatment of severe psoriasis and psoriatic arthritis with leflunomide.

Reich K, Hummel KM, Beckmann I, Mössner R, Neumann C. Reich K, et al. Br J Dermatol. 2002 Feb;146(2):335-6. doi: 10.1046/j.1365-2133.2002.4653_5.x. Br J Dermatol. 2002. PMID: 11903256 No abstract available.

3

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.

Reich K, Nestle FO, Papp K, Ortonne JP, Wu Y, Bala M, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CE. Reich K, et al. Br J Dermatol. 2006 Jun;154(6):1161-8. doi: 10.1111/j.1365-2133.2006.07237.x. Br J Dermatol. 2006. PMID: 16704649 Clinical Trial.

4

Treatment goals in psoriasis.

Reich K, Mrowietz U. Reich K, et al. J Dtsch Dermatol Ges. 2007 Jul;5(7):566-74. doi: 10.1111/j.1610-0387.2007.06343.x. J Dtsch Dermatol Ges. 2007. PMID: 17610606 Review. English, German.

5

Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year.

Rich P, Griffiths CE, Reich K, Nestle FO, Scher RK, Li S, Xu S, Hsu MC, Guzzo C. Rich P, et al. Among authors: reich k. J Am Acad Dermatol. 2008 Feb;58(2):224-31. doi: 10.1016/j.jaad.2007.07.042. Epub 2007 Dec 20. J Am Acad Dermatol. 2008. PMID: 18083272 Clinical Trial.

6

Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis.

Hüffmeier U, Lascorz J, Böhm B, Lohmann J, Wendler J, Mössner R, Reich K, Traupe H, Kurrat W, Burkhardt H, Reis A. Hüffmeier U, et al. Among authors: reich k. J Invest Dermatol. 2009 Feb;129(2):355-8. doi: 10.1038/jid.2008.233. Epub 2008 Sep 18. J Invest Dermatol. 2009. PMID: 18800148 Free article.

7

Adverse drug events in infliximab-treated patients compared with the general and psoriasis populations.

Menter A, Reich K, Gottlieb AB, Bala M, Li S, Hsu MC, Guzzo C, Diels J, Gelfand JM. Menter A, et al. Among authors: reich k. J Drugs Dermatol. 2008 Dec;7(12):1137-46. J Drugs Dermatol. 2008. PMID: 19137767

8

Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.

Reich K, Krüger K, Mössner R, Augustin M. Reich K, et al. Br J Dermatol. 2009 May;160(5):1040-7. doi: 10.1111/j.1365-2133.2008.09023.x. Epub 2009 Feb 4. Br J Dermatol. 2009. PMID: 19210498

9

Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey.

Radtke MA, Reich K, Blome C, Rustenbach S, Augustin M. Radtke MA, et al. Among authors: reich k. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):683-91. doi: 10.1111/j.1468-3083.2009.03159.x. Epub 2009 Mar 6. J Eur Acad Dermatol Venereol. 2009. PMID: 19309433

10

Approach to managing patients with nail psoriasis.

Reich K. Reich K. J Eur Acad Dermatol Venereol. 2009 Sep;23 Suppl 1:15-21. doi: 10.1111/j.1468-3083.2009.03364.x. J Eur Acad Dermatol Venereol. 2009. PMID: 19686381 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

582 results

Search Page